The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Etiology and pathogenesis of Parkinson's disease
Abstract
The past 25 years have seen a major expansion of knowledge concerning the cause of Parkinson's disease provided by an understanding of environmental and genetic factors that underlie the loss of nigral dopaminergic neurons. Based on the actions of toxins, postmortem investigations, and gene defects responsible for familial Parkinson's disease, there is now a general consensus about the mechanisms of cell death that contribute to neuronal loss in Parkinson's disease. Mitochondrial dysfunction, oxidative stress, altered protein handling, and inflammatory change are considered to lead to cell dysfunction and death by apoptosis or autophagy. Ageing is the single most important risk factor for Parkinson's disease, and the biochemical changes that are a consequence of aging amplify these abnormalities in Parkinson's disease brain. What remains to be determined is the combination and sequence of events leading to cell death and whether this is identical in all brain regions where pathology occurs and in all individuals with Parkinson's disease. Focusing on those events that characterize Parkinson's disease, namely, mitochondrial dysfunction and Lewy body formation, may be the key to further advancing the understanding of pathogenesis and to taking these mechanisms forward as a means of defining targets for neuroprotection. © 2011 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Self-citationBurns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., & Kopin, I. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4546 · Cited by 2,149
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Self-citationMitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L. A., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911187107 · Cited by 1,616
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Self-citationDevi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., & Anandatheerthavarada, H. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710012200 · Cited by 1,080
DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043 · cited 1×
“production might occur, but this is not specific, as it is found in almost all other neurodegenerative diseases.(30) However, deficiencies in the major antioxidant enzyme systems in brain, catalase, superoxide dismutase, and glutathione peroxidase, along with a reduction in the levels of reduced glutathione, suggested…”
BackgroundSelf-citationGegg, M. E., Cooper, J. M., Chau, K.-Y., Rojo, M., Schapira, A. H. V., & Taanman, J.-W. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq419 · Cited by 910
Self-citationMitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Self-citationBiochemical pathophysiology of Parkinson's disease.
Hornykiewicz, O., & Kish, S. J. (1987) · PubMed · Cited by 849
Alam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845
Self-citationMcCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., & Di Monte, D. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838
Pathogenic Lysosomal Depletion in Parkinson's Disease
Dehay, B., Bové, J., Rodríguez-Muela, N., Perier, C., Recasens, A., Boya, P., & Vila, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1920-10.2010 · Cited by 825
CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL
Scoppetta, C., & Vaccario, M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 753
Missing pieces in the Parkinson's disease puzzle
Obeso, J. A., Rodriguez-Oroz, M. C., Goetz, C. G., Marin, C., Kordower, J. H., Rodriguez, M., Hirsch, E. C., Farrer, M., Schapira, A. H. V., & Halliday, G. (2010) · Nature Medicine · doi:10.1038/nm.2165 · Cited by 734
Self-citationA radical hypothesis for neurodegeneration
Olanow, C. W. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90070-3 · Cited by 722
Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4308-05.2006 · Cited by 684
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Schapira, A. H. V., Mann, V. M., Cooper, J. M., Dexter, D., Daniel, S. E., Jenner, P., Clark, J. B., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05809.x · Cited by 673
Self-citationAltered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573
Self-citationChaperone-Mediated Autophagy Markers in Parkinson Disease Brains
Alvarez-Erviti, L., Rodriguez-Oroz, M. C., Cooper, J. M., Caballero, C., Ferrer, I., Obeso, J. A., & Schapira, A. H. V. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.198 · Cited by 554
Self-citationSystemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
McNaught, K. S. P., Perl, D. P., Brownell, A., & Olanow, C. W. (2004) · Annals of Neurology · doi:10.1002/ana.20186 · Cited by 548
Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547
Self-citationFailure of the ubiquitin-proteasome system in Parkinson’s disease
McNaught, K. S. P., Olanow, C. W., Halliwell, B., Isacson, O., & Jenner, P. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086067 · Cited by 519
Self-citationInhibition of mitochondrial fusion by α‐synuclein is rescued by PINK1, Parkin and DJ‐1
Kamp, F., Exner, N., Lutz, A. K., Wender, N., Hegermann, J., Brunner, B., Nuscher, B., Bartels, T., Giese, A., Beyer, K., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.223 · Cited by 479
A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra
Saggu, H., Cooksey, J., Dexter, D., Wells, F. R., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454
Self-citationZhu, J.-H., Horbinski, C., Guo, F., Watkins, S., Uchiyama, Y., & Chu, C. T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060524 · Cited by 445
Chen, Y., McMillan-Ward, E., Kong, J., Israels, S. J., & Gibson, S. B. (2007) · Journal of Cell Science · doi:10.1242/jcs.011163 · Cited by 443
Ageing, neurodegeneration and Parkinson's disease
Hindle, J. V. (2010) · Age and Ageing · doi:10.1093/ageing/afp223 · Cited by 430
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 424
Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study
Dexter, D. T., Holley, A. E., Flitter, W. D., Slater, T. F., Wells, F. R., Daniel, S. E., Lees, A. J., Jenner, P., & Marsden, C. D. (1994) · Movement Disorders · doi:10.1002/mds.870090115 · Cited by 407
Self-citationMcGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400
Genetic and environmental factors in the cause of Parkinson's disease
Warner, T. T., & Schapira, A. H. V. (2003) · Annals of Neurology · doi:10.1002/ana.10487 · Cited by 399
Self-citationNeuroinflammatory processes in Parkinson's disease
Hunot, S., & Hirsch, E. C. (2003) · Annals of Neurology · doi:10.1002/ana.10481 · Cited by 398
Dopamine turnover and glutathione oxidation: implications for Parkinson disease.
Spina, M. B., & Cohen, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1398 · Cited by 395
Tofaris, G. K., Razzaq, A., Ghetti, B., Lilley, K. S., & Spillantini, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308041200 · Cited by 361
Mitochondrial function and morphology are impaired in parkin‐mutant fibroblasts
Mortiboys, H., Thomas, K. J., Koopman, W. J. H., Klaffke, S., Abou‐Sleiman, P., Olpin, S., Wood, N. W., Willems, P. H. G. M., Smeitink, J. A. M., Cookson, M. R., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21492 · Cited by 341
Bedford, L., Hay, D., Devoy, A., Paine, S., Powe, D. G., Seth, R., Gray, T., Topham, I., Fone, K., Rezvani, N., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2218-08.2008 · Cited by 327 · cited 1×
“However, the observations in postmortem tissue remain robust, and transgenic mice with selective proteasomal deletions also appear to show nigral degeneration.(83) Recently attention has turned to the role of autophagy in neuronal degeneration in PD.”
Background1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset
Jenner, P. G., Rupniak, N. M. J., Rose, S., Kelly, E., Kilpatrick, G. J., Lees, A. J., & MARSDEN, C. D. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90467-1 · Cited by 323
Self-citationMcNaught, K. S. P., Mytilineou, C., JnoBaptiste, R., Yabut, J., Shashidharan, P., Jenner, P., & Olanow, C. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00821.x · Cited by 304
Self-citationDexter, D. T., Jenner, P., Schapira, A. H. V., Marsden, C. D., & The Royal Kings and Queens Parkinson's Disease Research Group (1992) · Annals of Neurology · doi:10.1002/ana.410320716 · Cited by 292
Self-citationKikuchi, A., Takeda, A., Onodera, H., Kimpara, T., Hisanaga, K., Sato, N., Nunomura, A., Castellani, R. J., Perry, G., Smith, M. A., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0466 · Cited by 289
Shimura, H., Hattori, N., Kubo, S.-I., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<668::aid-ana19>3.0.co;2-z · Cited by 282
Aggresome‐related biogenesis of Lewy bodies
McNaught, K. S. P., Shashidharan, P., Perl, D. P., Jenner, P., & Olanow, C. W. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02301.x · Cited by 279
Self-citationProteasome inhibition causes nigral degeneration with inclusion bodies in rats
McNaught, K. S. P., Bj??rklund, L. M., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2002) · Neuroreport · doi:10.1097/00001756-200208070-00018 · Cited by 274
Self-citationNew insights into the cause of Parkinson's disease
Jenner, P., Schapira, A. H. V., & Marsden, C. D. (1992) · Neurology · doi:10.1212/wnl.42.12.2241 · Cited by 270
Self-citationPINK1-linked parkinsonism is associated with Lewy body pathology
Samaranch, L., Lorenzo-Betancor, O., Arbelo, J. M., Ferrer, I., Lorenzo, E., Irigoyen, J., Pastor, M. A., Marrero, C., Isla, C., Herrera-Henriquez, J., et al. (2010) · Brain · doi:10.1093/brain/awq051 · Cited by 258
Complex I, iron, and ferritin in Parkinson's disease substantia nigra
Mann, V. M., Cooper, J. M., Daniel, S. E., Srai, K., Jenner, P., Marsden, C. D., & Schapira, A. H. V. (1994) · Annals of Neurology · doi:10.1002/ana.410360612 · Cited by 251
Self-citationEtiology of Parkinson’s disease
Schapira, A. H. V. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s10 · Cited by 250
Self-citationMPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.
Langston, J. W., Langston, E. B., & Irwin, I. (1984) · PubMed · Cited by 249
Neurobiology and treatment of Parkinson's disease
Schapira, A. H. V. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.005 · Cited by 247
Self-citationIravani, M. M., Kashefi, K., Mander, P., Rose, S., & Jenner, P. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00562-0 · Cited by 247
Self-citationLocalization of α-synuclein to mitochondria within midbrain of mice
Li, W.-W., Yang, R., Guo, J.-C., Ren, H.-M., Zha, X.-L., Cheng, J.-S., & Cai, D.-F. (2007) · NeuroReport · doi:10.1097/wnr.0b013e3282f03db4 · Cited by 244
McNaught, K. S. P., Belizaire, R., Jenner, P., Olanow, C. W., & Isacson, O. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00296-3 · Cited by 232
Self-citationOn the origin and significance of neuromelanin.
Dg, G. (1979) · PubMed · Cited by 223
Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease
Surmeier, D. J., Guzman, J. N., & Sanchez-Padilla, J. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.003 · Cited by 222
Evidence for mitochondrial dysfunction in Parkinson's disease—a critical appraisal
Schapira, A. H. V. (1994) · Movement Disorders · doi:10.1002/mds.870090202 · Cited by 219
Self-citationBarcia, C., Bahillo, A. S., Fernández‐Villalba, E., Bautista, V., Poza Y Poza, M., Fernández‐Barreiro, A., Hirsch, E. C., & Herrero, M. (2004) · Glia · doi:10.1002/glia.20015 · Cited by 206
Molecular and clinical prodrome of Parkinson disease: implications for treatment
Schapira, A. H. V., & Tolosa, E. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.52 · Cited by 202
Self-citationLiu, G., Zhang, C., Yin, J., Li, X., Cheng, F., Li, Y., Yang, H., Uéda, K., Chan, P., & Yu, S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.056 · Cited by 201
Gegg, M. E., Cooper, J. M., Schapira, A. H. V., & Taanman, J.-W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004756 · Cited by 198
Self-citationGender differences in Parkinson's disease
Shulman, L. M. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80003-9 · Cited by 183
Mitochondrial dysfunction in Parkinson's disease
Schapira, A. H. V. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402160 · Cited by 175
Self-citationDiorthosubstituted Polychlorinated Biphenyls in Caudate Nucleus in Parkinson's Disease
Corrigan, F. M., Murray, L., Wyatt, C. L., & Shore, R. F. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6776 · Cited by 169
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases
Gu, M., Owen, A. D., Toffa, S. E. K., Cooper, J. M., Dexter, D. T., Jenner, P., Marsden, C. D., & Schapira, A. H. V. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00095-1 · Cited by 164
Self-citationMutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts
Grünewald, A., Voges, L., Raković, A., Kasten, M., Vandebona, H., Hemmelmann, C., Lohmann, K., Orolicki, S., Ramírez, A., Schapira, A. H. V., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012962 · Cited by 160
Self-citationOxidative Stress and Parkinson's Diseasea
Owen, A., Schapira, A. H. V., Jenner, P. G., & MARSDEN, C. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39064.x · Cited by 156
Self-citationUngerstedt, U., Ljungberg, T., & Steg, G. (1974) · PubMed · Cited by 138
Parkin is associated with cellular vesicles
Kubo, S., Kitami, T., Noda, S., Shimura, H., Uchiyama, Y., Asakawa, S., Minoshima, S., Shimizu, N., Mizuno, Y., & Hattori, N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00364.x · Cited by 137
Elevated Serum Pesticide Levels and Risk of Parkinson Disease
Richardson, J. R., Shalat, S. L., Buckley, B., Winnik, B., O’Suilleabhain, P. E., Diaz-Arrastia, R. R., REISCH, J. S., & German, D. C. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.89 · Cited by 137
McNaught, K. S. P., & Jenner, P. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732469.x · Cited by 132
Self-citationIravani, M. M., Leung, C. C. M., Sadeghian, M., Haddon, C. O., Rose, S., & Jenner, P. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04220.x · Cited by 126
Self-citationEtiology and Pathogenesis of Parkinson Disease
Schapira, A. H. V. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.04.004 · Cited by 120
Self-citationJenner, P. G. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00115-3 · Cited by 119
Self-citationGegg, M. E., & Schapira, A. H. V. (2011) · Autophagy · doi:10.4161/auto.7.2.14332 · Cited by 106
Self-citationChau, K., Ching, H. L., Schapira, A. H. V., & Cooper, J. A. D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06191.x · Cited by 106
Self-citationParkin expression in the adult mouse brain
Stichel, C. C., Augustin, M. A., Kühn, K., Zhu, X., Engels, P., Ullmer, C., & Lübbert, H. (2000) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2000.01314.x · Cited by 98
Oxidative stress in Parkinson's disease
Schapira, A. H. V. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01022.x · Cited by 91
Self-citationProteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons
Schapira, A. H. V., Cleeter, M. W. J., Muddle, J. R., Workman, J. M., Cooper, J. A. D., & King, R. H. M. (2006) · Annals of Neurology · doi:10.1002/ana.20934 · Cited by 91
Self-citationMcNaught, K. S. P., & Jenner, P. G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00415-9 · Cited by 89
Self-citationReproducible nigral cell loss after systemic proteasomal inhibitor administration to rats
Zeng, B., Bukhatwa, S., Hikima, A., Rose, S., & Jenner, P. G. (2006) · Annals of Neurology · doi:10.1002/ana.20932 · Cited by 76
Self-citationPerspectives on recent advances in the understanding and treatment of Parkinson's disease
Schapira, A. H., Agid, Y., Barone, P., Jenner, P., Lemke, M. R., Poewe, W., Rascol, O., Reichmann, H., & Tolosa, E. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02793.x · Cited by 69
Self-citationNitric oxide, glial cells and neuronal degeneration in parkinsonism
Hirsch, É. C., & Hunot, S. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01471-1 · Cited by 60
Hong, J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1344.054 · Cited by 59
The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease
Schapira, A. H. V. (2008) · Movement Disorders · doi:10.1002/mds.22146 · Cited by 56
Self-citationDysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor release
McNaught, K. S. P., & Jenner, P. G. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00982-4 · Cited by 43
Self-citationZeng, B. ‐., Iravani, M. M., Lin, S., Irifune, M., Kuoppamäki, M., Al‐Barghouthy, G., Smith, L., Jackson, M. J., Rose, S., Medhurst, A. D., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04718.x · Cited by 41
Self-citationBukhatwa, S., Iravani, M. M., Zeng, B., Cooper, J. D., Rose, S., & Jenner, P. G. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05956.x · Cited by 23
Self-citationIravani, M. M., Haddon, C. O., Rose, S., & Jenner, P. G. (2006) · Brain Research · doi:10.1016/j.brainres.2005.10.086 · Cited by 17
Self-citationLangston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
Bhat, A. H., Dar, K. B., Anees, S., Zargar, M. A., Masood, A., Sofi, M. A., & Ganie, S. A. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.07.025 · Cited by 928
Oxidative stress and Parkinson’s disease
Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00091 · Cited by 878
Role of Oxidative Stress in Parkinson's Disease
Hwang, O. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.11 · Cited by 835
Parkinson's Disease and Parkinsonism
Hayes, M. T. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.03.001 · Cited by 823
Metadata
- Authors
- Schapira, A. H., & Jenner, P.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2011-05
- Volume
- 26
- Issue
- 6
- Pages
- 1049-1055
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2085270307
- Cited by
- 657
- References
- 100
- FWCI
- 29.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.